Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-cell engagers
Pharma
Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia
Kyowa Kirin ended its autoimmune program after new cancer reports. Sanofi linked up with Sino Biopharm. BioNTech advanced a DualityBio ADC. And more.
Angus Liu
Mar 6, 2026 9:35am
China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia
Jan 9, 2026 3:00am
Pfizer, Akeso, Lilly and more—Fierce Pharma Asia
Nov 14, 2025 8:50am
J&J eyes earlier myeloma treatment with ph. 3 Tecvayli combo win
Oct 16, 2025 8:10am
Sanofi, Trump, VC capital crunch—Fierce Pharma Asia
Aug 8, 2025 9:32am
Genmab touts new data that set up Epkinly for FL expansion
Aug 8, 2025 7:25am
